Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Lurdes Y T, Inoue"'
Autor:
Dylan Eiger, Daniel P. Fishbein, Zainab Samad, Jeanne E. Poole, Kerry L. Lee, Daniel Friedman, Sana M. Al-Khatib, Gillian D Sanders, Daniel B. Mark, Qijun Li, Lurdes Y. T. Inoue, Gust H. Bardy
Publikováno v:
Cardiology Journal. 29:978-984
Background: Many patients in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) had a significant improvement (> 10%) in the left ventricular ejection fraction (LVEF) during the course of the study, but the factors and outcomes associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6e5420bcbf2e71b4c0310cff047d5c
https://doi.org/10.5603/cj.a2020.0187
https://doi.org/10.5603/cj.a2020.0187
Autor:
Charles J. Wolock, Aasthaa Bansal, David L. Veenstra, Anirban Basu, Lurdes Y. T. Inoue, Patrick J. Heagerty
Publikováno v:
Med Decis Making
Background Patient surveillance using repeated biomarker measurements presents an opportunity to detect and treat disease progression early. Frequent surveillance testing using biomarkers is recommended and routinely conducted in several diseases, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eece77ff4b54d061924c2a4e1d616329
https://doi.org/10.1177/0272989x211049213
https://doi.org/10.1177/0272989x211049213
Publikováno v:
Medical decision making : an international journal of the Society for Medical Decision Making. 42(4)
Background An established risk model may demonstrate miscalibration, meaning predicted risks do not accurately capture event rates. In some instances, investigators can identify and address the cause of miscalibration. In other circumstances, it may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea3d495b1883f579edc832e8fbd6c3f6
https://pubmed.ncbi.nlm.nih.gov/34605718
https://pubmed.ncbi.nlm.nih.gov/34605718
Autor:
Brystana G. Kaufman, Marat Fudim, Anthony Tang, Sarah A. Goldstein, Daniel J. Friedman, Valentina Kutyifa, Sana M. Al-Khatib, Daniel E. Schaber, J. Kelly Davis, Lurdes Y. T. Inoue, Gillian D Sanders, Kathryn R Lallinger, Fatima Ali-Ahmed, Michael R. Gold, Cecilia Linde, William T. Abraham, Frederik Dalgaard, Anne B. Curtis, John G.F. Cleland, Robyn Fortman
Publikováno v:
Am Heart J
Background:\ud \ud Although cardiac resynchronization therapy (CRT) is effective for some patients with heart failure and a reduced left ventricular ejection fraction (HFrEF), evidence gaps remain for key clinical and policy areas. The objective of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::619cce20d689cb804523facfbe9e110c
https://pubmed.ncbi.nlm.nih.gov/32163753
https://pubmed.ncbi.nlm.nih.gov/32163753
Autor:
Lurdes Y. T. Inoue, Jonathan R. Stroud, Jane M. Lange, Yue Zhang, Rebecca A. Hubbard, B. A. Salim
Publikováno v:
Statistics in Medicine. 35:4980-4993
Diagnostic evaluation of suspected breast cancer due to abnormal screening mammography results is common, creates anxiety for women and is costly for the healthcare system. Timely evaluation with minimal use of additional diagnostic testing is key to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e740864d230244324c5019c82670636
https://doi.org/10.1002/sim.7055
https://doi.org/10.1002/sim.7055
Autor:
Roman Gulati, Ruth Etzioni, Laurence Klotz, David F. Penson, Donna P. Ankerst, Alexandre Mamedov, Bruce J. Trock, Janet E. Cowan, Matthew R. Cooperberg, Daniel W. Lin, Peter R. Carroll, Lurdes Y. T. Inoue, Lisa F. Newcomb, H. Ballentine Carter, Amy Leonardson
Publikováno v:
The Journal of urology. 200(3)
Background Active surveillance (AS) is increasingly accepted for managing low-risk prostate cancer, yet there is no consensus about implementation. This lack of consensus is due in part to uncertainty about risks for disease progression, which have n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f400740a10ea786f72e3c64316dad4f1
https://pubmed.ncbi.nlm.nih.gov/29181514
https://pubmed.ncbi.nlm.nih.gov/29181514
Autor:
Jarcy Zee, Pamela A. Shaw, William Mietlowski, Ying Huang, Eve H. Pickering, Jeremy M. G. Taylor, Michael W. Kattan, Herbert I. Weisberg, Lurdes Y. T. Inoue, Songbai Wang, H. M James Hung, Susan S. Ellenberg, Stuart G. Baker
Publikováno v:
Clinical Trials. 12:365-373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6cac8545f3be6fcab51814b60d69d56
https://doi.org/10.1177/1740774515590089
https://doi.org/10.1177/1740774515590089
Autor:
Arthur J. Moss, J. Thomas Bigger, Daniel B. Mark, Gust H. Bardy, Alan H. Kadish, Sana M. Al-Khatib, Paul Dorian, Richard C. Steinman, Joo Yoon Han, Peter J. Kudenchuk, Rex Edwards, Alfred E. Buxton, Al Hallstrom, Paul L. Hess, Kerry L. Lee, Gillian D Sanders, Lurdes Y. T. Inoue, Riccardo Cappato
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 8:179-186
Background— The impact of patient age on the risks of death or rehospitalization after primary prevention implantable cardioverter-defibrillator (ICD) placement is uncertain. Methods and Results— Data from 5 major ICD trials were merged: the Mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14ebf62c67056d21a8ca61a368eb5fa
https://doi.org/10.1161/circoutcomes.114.001306
https://doi.org/10.1161/circoutcomes.114.001306
Autor:
Alan H. Kadish, Gust H. Bardy, Arthur J. Moss, Jeanne E. Poole, J. Thomas Bigger, Kerry L. Lee, Daniel B. Mark, Alfred E. Buxton, Lurdes Y. T. Inoue, Peter J. Kudenchuk, Emily P. Zeitler, Paul Dorian, Joo Yoon Han, Riccardo Cappato, Gillian D Sanders, Daniel J. Friedman, Sana M. Al-Khatib
Background No precise tools exist to predict appropriate shocks in patients with a primary prevention ICD. We sought to identify characteristics predictive of appropriate shocks in patients with a primary prevention implantable cardioverter defibrill
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::babe7e1054d52f53dec2d04dda5b1ee7
https://europepmc.org/articles/PMC5693305/
https://europepmc.org/articles/PMC5693305/
Autor:
Christopher B. Fordyce, Daniel B. Mark, Alan H. Kadish, Alfred E. Buxton, Lurdes Y. T. Inoue, J. Thomas Bigger, Abhinav Sharma, Gust H. Bardy, Arthur J. Moss, Eric D. Peterson, Justin A. Ezekowitz, Paul Dorian, Peter J. Kudenchuk, G. Michael Felker, Lauren B. Cooper, Daniel J. Friedman, Gillian D Sanders, Riccardo Cappato, Jeanne E. Poole, Kerry L. Lee, Sana M. Al-Khatib, Richard C. Steinman
Publikováno v:
European journal of heart failure. 20(6)
Aim There is limited information on the outcomes after primary prevention implantable cardioverter-defibrillator (ICD) implantation in patients with heart failure (HF) and diabetes. This analysis evaluates the effectiveness of a strategy of ICD plus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9647d7fc99313bdef4cf2bcee93bddc
https://pubmed.ncbi.nlm.nih.gov/29761861
https://pubmed.ncbi.nlm.nih.gov/29761861